Anti-AKT3 + AKT2 + AKT1 抗体 [RM1043] (ab300473)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit recombinant multiclonal [RM1043] to AKT3 + AKT2 + AKT1
- Suitable for: IHC-Fr, Flow Cyt (Intra), IP, ICC/IF, WB, IHC-P
- Reacts with: Mouse, Rat, Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-AKT3 + AKT2 + AKT1 antibody [RM1043] -
製品の詳細
Rabbit recombinant multiclonal [RM1043] to AKT3 + AKT2 + AKT1 -
由来種
Rabbit -
アプリケーション
適用あり: IHC-Fr, Flow Cyt (Intra), IP, ICC/IF, WB, IHC-Pmore details -
種交差性
交差種: Mouse, Rat, Human -
免疫原
This product was produced with the following immunogens:
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers. -
ポジティブ・コントロール
- WB: MCF7 (human breast adenocarcinoma epithelial), HeLa (human cervix adenocarcinoma epithelial), NIH/3T3 (mouse embryonic fibroblast), RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage), PC-12 (Rat adrenal gland pheochromocytoma). AKT1/2/3 recombinant protein his-tagged. IHC-P: Tissue lysates: human cerebrum and breast carcinoma, mouse and rat cerebrum. IHC-Fr.: Mouse and rat cerebral cortex. ICC/IF: MCF7, NIH/3T3. Flow cyt (intra): MCF7, NIH/3T3. IP: NIH/3T3, HeLa.
-
特記事項
This product is a recombinant multiclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
For more information see here.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
バッファー
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
Recombinant Multiclonal -
クローン名
RM1043 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab300473の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
IHC-Fr |
1/100.
|
|
Flow Cyt (Intra) |
1/500.
|
|
IP |
1/30.
|
|
ICC/IF |
1/50.
|
|
WB |
1/1000. Predicted molecular weight: 56 kDa.
|
|
IHC-P |
1/2000. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
|
特記事項 |
---|
IHC-Fr
1/100. |
Flow Cyt (Intra)
1/500. |
IP
1/30. |
ICC/IF
1/50. |
WB
1/1000. Predicted molecular weight: 56 kDa. |
IHC-P
1/2000. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
ターゲット情報
-
細胞内局在
AKT3: Cytoplasm. Membrane. Membrane-associated after cell stimulation leading to its translocation. AKT1: Cytoplasm. Nucleus. Cell membrane. Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Phosphorylation on Tyr-176 by TNK2 results in its localization to the cell membrane where it is targeted for further phosphorylations on Thr-308 and Ser-473 leading to its activation and the activated form translocates to the nucleus. -
参照データベース
- Entrez Gene: 10000 Human
- Entrez Gene: 207 Human
- Entrez Gene: 208 Human
- Entrez Gene: 11651 Mouse
- Entrez Gene: 11652 Mouse
- Entrez Gene: 23797 Mouse
- Entrez Gene: 24185 Rat
- Entrez Gene: 25233 Rat
see all
画像
-
All lanes : Anti-AKT3 + AKT2 + AKT1 antibody [RM1043] (ab300473) at 1/1000 dilution
Lane 1 : MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate
Lane 2 : HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 3 : NIH/3T3 (mouse embryonic fibroblast) whole cell lysate
Lane 4 : RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate
Lane 5 : PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
Exposure time: 15 secondsBlocking and dilution buffer and concentration: 5% NFDM/TBST.
-
All lanes : Anti-AKT3 + AKT2 + AKT1 antibody [RM1043] (ab300473) at 1/1000 dilution
Lane 1 : AKT1 recombinant protein containing his-tag (1-480 aa) 10ng
Lane 2 : AKT2 recombinant protein containing GST-tag (1-481 aa) 10ng
Lane 3 : AKT3 recombinant protein containing GST-tag (1-479 aa) 10ng
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 56 kDa
Observed band size: 56, 82 kDa why is the actual band size different from the predicted?
Exposure time: 8 secondsBlocking and dilution buffer and concentration: 5% NFDM/TBST.
-
Immunohistochemical analysis of paraffin-embedded human cerebrum tissue labeling AKT1 + AKT2 + AKT3 with ab300473 at 1/2000, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human cerebrum is observed. The section was incubated with ab300473 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: PBS was used instead of primary antibody followed by ready to use secondary antibody LeicaDS9800 (BOND™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins was used.
-
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue labeling AKT1 + AKT2 + AKT3 with ab300473 at 1/2000, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human breast carcinoma is observed. The section was incubated with ab300473 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: PBS was used instead of primary antibody followed by ready to use secondary antibody LeicaDS9800 (BOND™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins was used.
-
Immunohistochemical analysis of paraffin-embedded mouse cerebrum tissue labeling AKT1 + AKT2 + AKT3 with ab300473 at 1/2000, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on mouse cerebrum is observed. The section was incubated with ab300473 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: PBS was used instead of primary antibody followed by ready to use secondary antibody LeicaDS9800 (BOND™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins was used.
-
Immunohistochemical analysis of paraffin-embedded rat cerebrum tissue labeling AKT1 + AKT2 + AKT3 with ab300473 at 1/2000, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on rat cerebrum is observed. The section was incubated with ab300473 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: PBS was used instead of primary antibody followed by ready to use secondary antibody LeicaDS9800 (BOND™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins was used.
-
Immunohistochemical analysis of paraffin-embedded human skeletal muscle tissue labeling AKT1 + AKT2 + AKT3 with ab300473 at 1/2000, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Low expression on human skeletal muscle is observed. The section was incubated with ab300473 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: PBS was used instead of primary antibody followed by ready to use secondary antibody LeicaDS9800 (BOND™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins was used.
-
Immunohistochemical analysis of 4% PFA-fixed, 0.2% Triton X-100 permeabilized frozen mouse cerebral cortex (fresh) tissue labeling AKT1 + AKT2 + AKT3 with ab300473 at 1/100 dilution (4.4 μg/ml) followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preabsorbed at 1/1000 dilution (2 µg/mL) (Green). Positive staining on mouse cerebral cortex is observed. The nuclear counterstain was DAPI (Blue).
-
Immunohistochemical analysis of 4% PFA-fixed, 0.2% Triton X-100 permeabilized frozen rat cerebral cortex (fresh) tissue labeling AKT1 + AKT2 + AKT3 with ab300473 at 1/100 dilution (4.4 μg/ml) followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preabsorbed at 1/1000 dilution (2 µg/mL) (Green). Positive staining on rat cerebral cortex is observed. The nuclear counterstain was DAPI (Blue).
-
Immunofluorescent analysis of 4% paraformaldehyde fixed and 0.1% TritonX-100 permeabilized MCF7 (human breast adenocarcinoma epithelial cell)labeling AKT1 + AKT2 + AKT3 with ab300743 at 1/50 dilution (8.8 μg/ml), followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488, Green) preadsorbed at 1:1000 (2 μg/mL). Confocal image showing nuclear and cytoplasmic staining in MCF7 cell line.
Ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) (Red) was used as a counterstain at 1:200 dilution (2.5 μg/ml). Nuclear counter satin is DAPI.
-
Immunofluorescent analysis of 4% paraformaldehyde fixed and 0.1% TritonX-100 permeabilized NIH/3T3 (mouse embryonic fibroblast) labeling AKT1 + AKT2 + AKT3 with ab300743 at 1/50 dilution (8.8 μg/ml), followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488, Green) preadsorbed at 1:1000 (2 μg/mL). Confocal image showing nuclear and cytoplasmic staining in NIH/3T3 cell line.
Ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) (Red) was used as a counterstain at 1:200 dilution (2.5 μg/ml). Nuclear counter satin is DAPI.
-
Intracellular flow cytometric analysis of 4% paraformaldehyde fixed and 90% methanol permeabilized MCF7 (human breast adenocarcinoma epithelial cell) cells labelling AKT1 + AKT2 + AKT3 with ab300473 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
-
Intracellular flow cytometric analysis of 4% paraformaldehyde fixed and 90% methanol permeabilized NIH/3T3 (mouse embryonic fibroblast) cells labelling AKT1 + AKT2 + AKT3 with ab300473 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
-
AKT1 + AKT2 + AKT3 was immunoprecipitated from 0.35 mg NIH/3T3 (mouse embryonic fibroblast) whole cell lysate 10 µg with ab300473 at 1/30 dilution (2 µg in 0.35 mg lysates). Western blot was performed on the immunoprecipitate using ab300473 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1: NIH/3T3 (mouse embryonic fibroblast) whole cell lysate 10 µg (Input)
Lane 2: ab300473 IP in NIH/3T3 whole cell lysate
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab300473 in NIH/3T3 whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 6 seconds.
-
AKT1 + AKT2 + AKT3 was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate with ab300473 at 1/30 dilution (2 µg in 0.35 mg lysates). Western blot was performed on the immunoprecipitate using ab300473 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1: HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10 µg (Input)
Lane 2: ab300473 IP in HeLa whole cell lysate
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab300473 in HeLa whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 6 seconds.
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (2)
ab300473 は 2 報の論文で使用されています。
- Liang C et al. Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K/AKT pathway. Pharm Biol 61:581-589 (2023). PubMed: 36994813
- Chen Z et al. Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal. J Oncol 2022:6435431 (2022). PubMed: 36131794